Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Antwerp
About this trial
The goal of this observational cohort study is to learn about loss of muscle mass and muscle strength (sarcopenia) in patients with cirrhosis. The main question\[s\] it aims to answer are:
* what is the prevalence and development of sarcopenia in cirrhosis? * what is the role of malnutrition? Participants will
* undergo a muscle ultrasound of the lower and upper limb muscles * handgrip strength will be measured * malnutrition screening and assessment * complete a questionnaire to assess quality of life
Eligibility criteria
Qualifiers
diagnosis of cirrhosis and follow-up in the University Hospital of Antwerp
Disqualifiers
known patient will against participation in the study or against the measures applied in the study
a decision made prior to inclusion to stop further treatment of the patient within the next 24 hours
no complete remission of malignancy including hepatocellular carcinoma within the past 12 months
Trial design
Treatments tested in this trial
- ultrasound
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov